Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma

被引:8
|
作者
Woltsche, Nora [1 ]
Valentin, Katharina [1 ]
Hoeflechner, Lukas [1 ]
Guttmann, Andreas [1 ]
Horwath-Winter, Jutta [1 ]
Schneider, Mona Regina [1 ]
Ivastinovic, Domagoj [1 ]
Lindner, Marlene [2 ]
Schmetterer, Leopold [3 ,4 ]
Singh, Neena [5 ]
Riedl, Regina [6 ]
Buchmann, Arabella [7 ]
Khalil, Michael [7 ]
Lindner, Ewald [1 ]
机构
[1] Med Univ Graz, Dept Ophthalmol, Graz, Austria
[2] Med Univ Graz, Dept Dent, Graz, Steiermark, Austria
[3] Singapore Eye Res Inst, Ocular Imaging, Singapore, Singapore
[4] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[5] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[6] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria
[7] Med Univ Graz, Dept Neurol, Graz, Steiermark, Austria
关键词
Glaucoma; Anterior chamber; Aqueous humour; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; RISK; PROGRESSION; BLINDNESS;
D O I
10.1136/bjo-2021-320828
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/Aims Neurofilament light chain (NfL) levels in cerebrospinal fluid and serum are reliable indicators for neuroaxonal damage in a broad spectrum of neurodegenerative diseases. Herein, we investigate NfL levels in serum and anterior chamber fluid of patients with glaucoma. Methods Patients scheduled for routine glaucoma or cataract surgery were recruited for this study. Retinal nerve fibre layer thickness was measured by optical coherence tomography (OCT, Heidelberg Spectralis). NfL levels in serum and in anterior chamber fluid were analysed with Simoa SR-X Analyzer (Quanterix; NFLIGHT, Lexington, Massachusetts, USA). T-test was used for parametric data and Mann-Whitney-U test for nonparametric data. Spearman's rank-order correlation was used to investigate correlations. P values Results Sixty patients with glaucoma and 58 controls were enrolled. Serum NfL concentration of patients with glaucoma was similar to serum NfL concentration in controls (median (IQR); 22.7 (18.9) pg/mL vs 22.5 (24.0) pg/mL; p=0.763). A positive correlation of serum NfL with age was observed in both patients with glaucoma (r=0.77; p<0.001) and in the control group (r=0.82, p<0.001). In the anterior chamber fluid, the NfL concentration was substantially increased in patients with glaucoma compared with controls (20.7 (101.3) pg/mL vs 3.1 (2.9) pg/mL; p<0.001). Furthermore, we found a positive correlation of anterior chamber fluid NfL with preoperative intraocular pressure (r=0.39, p=0.003) and with retinal nerve fibre layer thickness (r=0.58, p<0.001). Conclusion NfL levels in anterior chamber fluid are elevated in patients with glaucoma and correlate with intraocular pressure and retinal nerve fibre layer thickness. The presented data strongly support anterior chamber fluid NfL as a new marker for glaucoma.
引用
收藏
页码:1432 / 1437
页数:6
相关论文
共 50 条
  • [1] Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
    Lin, Jonathan B.
    Pitts, Kristen M.
    El Helwe, Hani
    Neeson, Cameron
    Hall, Nathan E.
    Falah, Henisk
    Schultz, Stephanie A.
    Wang, Silas L.
    Lo, Kristine
    Song, Christian
    Margeta, Milica A.
    Sola-Del Valle, David
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 2209 - 2217
  • [2] Aqueous Humor Neurofilament Light Chain is a Marker of Neurodegeneration in Glaucoma
    Lin, Jonathan B.
    Pitts, Kristen
    Neeson, Cameron
    Hall, Nathan Eli
    Falah, Henisk
    El Helwe, Hani
    Wang, Silas
    Lo, Kristine
    Song, Christian
    Margeta, Milica
    Sola-Del Valle, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] Neurofilament light chain: a novel biomarker in patients with glaucoma
    Comacchio, Francesco
    Mariotto, Sara
    Neri, Enrico
    Bonora, Adriana
    Morbio, Roberta
    Pichler, Andreas
    Marchini, Giorgio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [4] Cerebrospinal fluid neurofilament light chain is a marker of disease activity in multiple sclerosis
    Poletto, E.
    Zanoni, M.
    Bongianni, M.
    Turatti, M.
    Calabrese, M.
    Marangi, A.
    Gobbin, F.
    Monaco, S.
    Benedetti, D.
    Gajofatto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 290 - 291
  • [5] Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies
    Canaslan, Sezgi
    Schmitz, Matthias
    Villar-Pique, Anna
    Maass, Fabian
    Gmitterova, Karin
    Varges, Daniela
    Lingor, Paul
    Llorens, Franc
    Hermann, Peter
    Zerr, Inga
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [6] Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
    Meeker, Karin L.
    Butt, Omar H.
    Gordon, Brian A.
    Fagan, Anne M.
    Schindler, Suzanne E.
    Morris, John C.
    Benzinger, Tammie L. S.
    Ances, Beau M.
    NEUROBIOLOGY OF DISEASE, 2022, 166
  • [7] Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients
    Simone, Isabella L.
    Ruggieri, Maddalena
    Tortelli, Rosanna
    D'Errico, Eustachio
    Leo, Antonio
    Mastrapasqua, Mariangela
    Leante, Rosaria
    Capozzo, Rosa
    Livrea, Paolo
    Logroscino, Giancarlo
    NEUROLOGY, 2010, 74 (09) : A179 - A180
  • [8] Serum neurofilament light chain as outcome marker for intensive care unit patients
    Fisse, Anna Lena
    Pitarokoili, Kalliopi
    Leppert, David
    Motte, Jeremias
    Pedreiturria, Xiomara
    Kappos, Ludwig
    Gold, Ralf
    Kuhle, Jens
    Yoon, Min-Suk
    JOURNAL OF NEUROLOGY, 2021, 268 (04) : 1323 - 1329
  • [9] Serum neurofilament light chain as outcome marker for intensive care unit patients
    Anna Lena Fisse
    Kalliopi Pitarokoili
    David Leppert
    Jeremias Motte
    Xiomara Pedreiturria
    Ludwig Kappos
    Ralf Gold
    Jens Kuhle
    Min-Suk Yoon
    Journal of Neurology, 2021, 268 : 1323 - 1329
  • [10] Validation of Plasma Neurofilament Light Chain as a Marker for α-Synucleinopathies
    Schmitz, Matthias
    Canaslan, Sezgi
    Villar-Pique, Anna
    Gmitterova, Karin
    Varges, Daniela
    Lingor, Paul
    Llorens, Franc
    Hermann, Peter
    Maass, Fabian
    Zerr, Inga
    MOVEMENT DISORDERS, 2021, 36 (11) : 2701 - 2703